CEDRUS’s Merck MRK Stock Holding History

CEDRUS’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$212K	Sell	1,869 -1,032	-36%	-$123K	0.08%	174
2024 Q2	$359K	Buy	2,901 +347	+14%	+$44.7K	0.18%	98
2024 Q1	$337K	Sell	2,554 -824	-24%	-$102K	0.18%	108
2023 Q4	$368K	Sell	3,378 -961	-22%	-$99.8K	0.23%	95
2023 Q3	$447K	Buy	4,339 +313	+8%	+$33.7K	0.32%	61
2023 Q2	$465K	Sell	4,026 -476	-11%	-$54K	0.33%	59
2023 Q1	$479K	Sell	4,502 -269	-6%	-$29K	0.34%	59
2022 Q4	$529K	Buy	4,771 +774	+19%	+$79.1K	0.43%	47
2022 Q3	$344K	Buy	3,997 +293	+8%	+$26.2K	0.32%	63
2022 Q2	$338K	Buy	3,704 +350	+10%	+$31K	0.33%	63
2022 Q1	$275K	Buy	3,354 +241	+8%	+$19K	0.25%	102
2021 Q4	$239K	Buy	+3,113	New	+$248K	0.23%	130

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CEDRUS's MRK Position: Q3 2024 in Review

CEDRUS reduced its Merck (MRK) stake by 36% in Q3 2024, selling an estimated $123K and leaving 1,869 shares worth $212K. The position accounts for 0.08% of the portfolio, ranked #174.

CEDRUS first reported a position in MRK in Q4 2021 and has held it in 12 quarters since. The position peaked at $529K in Q4 2022. 3,491 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

CEDRUS held 1,869 shares of Merck worth $212K as of Q3 2024.
CEDRUS sold 1,032 Merck shares in Q3 2024, an estimated $123K.
Merck made up 0.08% of CEDRUS's portfolio in Q3 2024, its #174 holding.
CEDRUS first reported a position in Merck in Q4 2021 and has held it in 12 quarters since.
CEDRUS's Merck position peaked at $529K in Q4 2022.
3,491 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.